MRI study of triple inhaler for COPD with breathlessness
Part of Lungs & breathing clinical trials.
This study uses a special MRI scan to see how well a single triple inhaler works for people with COPD who have moderate to severe shortness of breath or feel their health is not good. It compares two groups: those with a low risk of flare-ups and those with a high risk, to find out if the treatment helps both groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 85 years old.
- You have stable COPD and have been on a dual inhaler (LAMA/LABA or ICS/LABA) or starting maintenance therapy for at least 3 months.
- You feel short of breath when hurrying (mMRC score 2 or more) or your COPD affects your daily life (CAT score 10 or higher).
- You have had either 0 to 1 COPD flare-up in the past year (low risk) or 2 or more flare-ups (high risk).
- If you are a woman who could become pregnant, you must use an effective birth control method before and during the study.
- You must have no metal implants (like pacemakers) and not be claustrophobic, as you will have MRI scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment for people with COPD who still have frequent flare-ups despite using two maintenance inhalers. It aims to see if the study medicine can reduce these flare-ups.
This study looks at how a simple breath test (measuring nitric oxide in the air you breathe out) might help predict when COPD symptoms flare up. If you take triple inhaler therapy, this study could help you and your doctor better manage your condition and prevent future flare-ups.
This study uses special MRI and CT scans to take very detailed pictures of the lungs in people with mild asthma. The goal is to learn more about how asthma affects the lungs, which could help develop better treatments.
This study uses MRI scans to look at the airways in the lungs of children and teens with cystic fibrosis. It aims to see if MRI can detect changes in airway structure, which might help monitor the disease.
This study tests a new combination inhaler (fluticasone, formoterol, and glycopyrronium) for people with COPD. It aims to see if this triple therapy can improve breathing and quality of life compared to current treatments.
This study tests a triple-combination inhaler (budesonide, glycopyrronium, formoterol) against a placebo inhaler to see how it affects your heart and lungs if you have COPD and over-inflated lungs.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.